To keep you better informed about the biggest trends and developments affecting medication management and adherence, here are 10 of the most significant news reports published in October 2020. Highlights include a call for provider status for pharmacists, the role of telepharmacy, vaccine guidance and recommendations, COVID-19 and ebola treatments, and American Pharmacists Month.
Debbie Weitzman, president of pharmaceutical distribution for Cardinal Health, makes the case that "there has never been a better, or more important time, to grant provider status to pharmacists" in a column for Pharmacy Times.
New research published in Telemedicine Journal and e-Health finds that, "Telepharmacy can be used as a tool to reduce the burden on the healthcare system and improve drug dispensing safety in community pharmacies."
An article in the American Journal of Managed Care shares highlights from a panel discussion concerning changes in the healthcare landscape occurring due to COVID-19 pandemic, particularly around pharmacists' scope of practice and which of those changes are likely to persist following the health crisis.
The American Pharmacists Association (APhA) reports on new guidance from the U.S. Department of Health and Human Services (HHS) that expands the immunization authorities of state-licensed pharmacy interns and "qualified" pharmacy technicians during the public health emergency for purposes of administering childhood vaccines, COVID-19 vaccines, and COVID-19 tests.
APhA reports on a National Academies of Science, Engineering, and Medicine special committee tasked with developing a framework for the allocation and distribution of the COVID-19 vaccine stating that pharmacists should be in the first group to be vaccinated along with physicians, nurses, and other providers.
Healthcare innovation and public policy expert Gregory Downing, DO, PharmD, PhD, discusses trends and developments in areas including medication management, innovation, and public policy.
A new report from the Surgeon General highlights pharmacists' value in treating, controlling, and preventing hypertension and obstacles to their participation in these efforts, reports APhA.
Research by Kaiser Permanente published in the Journal of General Internal Medicine indicates that an outreach campaign directed at patients with type 2 diabetes can encourage them to use mail-order pharmacy services and improve medication adherence.
The U.S. Food and Drug Administration (FDA) approved the first treatment for COVID-19 requiring hospitalization — the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds). FDA also approved the first treatment for the Ebola virus — Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies.
In celebration of American Pharmacists Month, Cureatr's Director of Clinical Pharmacy Operations Rose Abraham, PharmD, identified some of the most significant and recent recognitions, contributions, and progress made by pharmacists.